tepadina
adienne s.r.l. s.u. - tiotepa - hematopoietisk stamcellstransplantation - antineoplastiska medel - i kombination med annan kemoterapi läkemedel:med eller utan total body irradiation (tbi), luftkonditionering behandling före allogen eller autolog hematopoetisk stamfader cell transplantation (hpct) i hematologiska sjukdomar hos vuxna och pediatriska patienter, när högdos kemoterapi med hpct stöd är lämpligt för behandling av solida tumörer hos vuxna och pediatriska patienter. det föreslås att tepadina måste förskrivas av läkare upplevt i luftkonditionering behandling före hematopoietisk stamfader cell transplantation.
trecondi
medac gesellschaft für klinische spezialpräparate mbh - treosulfan - hematopoietisk stamcellstransplantation - antineoplastiska medel - treosulfan in combination with fludarabine is indicated as part of conditioning treatment prior to allogeneic haematopoietic stem cell transplantation (allohsct) in adult patients and in paediatric patients older than one month with malignant and non-malignant diseases.
thiotepa riemser
esteve pharmaceuticals gmbh - tiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastiska medel - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.
pepaxti
oncopeptides ab - melphalan flufenamide hydrochloride - multipelt myelom - antineoplastiska medel - pepaxti is indicated, in combination with dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least three prior lines of therapies, whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one anti-cd38 monoclonal antibody, and who have demonstrated disease progression on or after the last therapy. for patients with a prior autologous stem cell transplantation, the time to progression should be at least 3 years from transplantation (see section 4.
doxorubicin accord 2 mg/ml koncentrat till infusionsvätska, lösning
accord healthcare b.v. - doxorubicinhydroklorid - koncentrat till infusionsvätska, lösning - 2 mg/ml - doxorubicinhydroklorid 2 mg aktiv substans - doxorubicin
fludara 10 mg filmdragerad tablett
genzyme europe bv - fludarabinfosfat - filmdragerad tablett - 10 mg - fludarabinfosfat 10 mg aktiv substans; laktosmonohydrat hjälpämne - fludarabin
fludara 10 mg filmdragerad tablett
orifarm ab - fludarabinfosfat - filmdragerad tablett - 10 mg - laktosmonohydrat hjälpämne; fludarabinfosfat 10 mg aktiv substans - fludarabin
fludara 10 mg filmdragerad tablett
2care4 aps - fludarabinfosfat - filmdragerad tablett - 10 mg - laktosmonohydrat hjälpämne; fludarabinfosfat 10 mg aktiv substans - fludarabin
fludara 10 mg filmdragerad tablett
orifarm ab - fludarabinfosfat - filmdragerad tablett - 10 mg - laktosmonohydrat hjälpämne; fludarabinfosfat 10 mg aktiv substans - fludarabin
fludara 10 mg filmdragerad tablett
paranova läkemedel ab - fludarabinfosfat - filmdragerad tablett - 10 mg - laktosmonohydrat hjälpämne; fludarabinfosfat 10 mg aktiv substans - fludarabin